{"0": "ABG in CD", "1": "ABI in PAD", "2": "APOE in CD", "3": "Beta blockers in CD", "4": "CKD contribution", "5": "CRISPR", "6": "CRP in CD", "7": "CSVD contribution", "8": "CT aniography vs conventional aniography", "9": "CTEPH  differ from other forms", "10": "CTEPH and IPH", "11": "CTPA in pulmonary embolism", "12": "DVT to PE", "13": "D_dimer testing", "14": "ECG report", "15": "EGDT in septic", "16": "ETCO2 level assist", "17": "FFR in CD", "18": "FFRCT in treatments", "19": "HFpEF mimic heart failure", "20": "HRV in CD", "21": "INOCA patients", "22": "LGE effect", "23": "Lbbb block MD", "24": "MRI in identifying MD", "25": "MitraClip procedure", "26": "NAFLD contribution", "27": "OSA contribution to hypertension", "28": "PFO closure", "29": "Q waves in ECG", "30": "SGLT2 in CD", "31": "ST2 and galectin3", "32": "Systolic diastolic dysfunction", "33": "TBI to improve accuracy in PAD", "34": "TCD access cerebrovascular reserve capacity", "35": "TVR in elderly patients", "36": "Takotsubo cardiomypathy", "37": "VADS enhance survival rates", "38": "adipose tissue function", "39": "affect of psychosocial stress", "40": "affirm", "41": "antiplatelet therapy", "42": "arial fibrillations in embolic", "43": "atrial septal aneurysm", "44": "bot_challenge", "45": "cardioprotective mechanisms of SGLT2", "46": "care testing improve diagnosis", "47": "causes for HD", "48": "celebral autoregulation in ischemic stroke", "49": "cholestrol and HD", "50": "chronic hyperglycemia and diabetic cardiomyopathy", "51": "common_to_male_or_female", "52": "coronary slow flow phenomenon", "53": "coronary vasospastic angina", "54": "cryptogenic strokes", "55": "deny", "56": "detection of pathogenic variants in the TTN gene", "57": "diabetes and HD", "58": "diagnosing criteria", "59": "difference between cardiac and non cardiac pain", "60": "doppler ultrasound in ID", "61": "echocardiography in Ischemic", "62": "endothelial dysfunction and vascular disease", "63": "endothelin receptors in PAH", "64": "familial hypercholesterolemia", "65": "gene environment in hypertension", "66": "genetics and HD", "67": "glucocorticoids affect in HD", "68": "goodbye", "69": "greet", "70": "hw to prevent", "71": "hypercholesterolemia in CD", "72": "hypertension", "73": "hypertension treatments", "74": "hypothyroidism contribution to atherosclerosis", "75": "impact of AGEs", "76": "impedance cardiography", "77": "incretin based therapies", "78": "inform_heart_disease", "79": "insulin resistance in endothelial dysfunction", "80": "intermittent fasting effects", "81": "lactate clearence in sepsis", "82": "lactate levels in MD", "83": "lipid  panel in CD", "84": "lipoprotein in LDL", "85": "lipoprotein levels in CD", "86": "manage atrial fibrillations", "87": "mechanical thrombectomy", "88": "mitochondrial dysfunction", "89": "mood_great", "90": "mood_unhappy", "91": "nations affected", "92": "neuroimaging differentiate", "93": "perfusion weighted MRI", "94": "permissive hypertension in hemorrhagic shock", "95": "pharmacogenomics in CD", "96": "pharmacogenomics in hyperlimidia", "97": "polygenic risk", "98": "pulmonary edema", "99": "right catherization", "100": "role ECMO", "101": "role of NOACs", "102": "role of PCI", "103": "role of omega3 fatty acids", "104": "smoking to HD", "105": "spirometry", "106": "symptoms of HD", "107": "therapies for PAH", "108": "troponin I and troponin T in MD", "109": "troponin levels", "110": "types of HD", "111": "use of AI in wearables", "112": "venous stasis in CVI", "113": "what is CAD", "114": "what types tests"}